A phase I clinical trial of lethally irradiated allogeneic pancreatic tumor cells transfected with the GM-CSF gene for the treatment of pancreatic adenocarcinoma.
Jaffee
E M
EM
Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA. ejaffee@welchlink.welch.jhu.edu
Abrams
R
R
Cameron
J
J
Donehower
R
R
Duerr
M
M
Gossett
J
J
Greten
T F
TF
Grochow
L
L
Hruban
R
R
Kern
S
S
Lillemoe
K D
KD
O'Reilly
S
S
Pardoll
D
D
Pitt
H A
HA
Sauter
P
P
Weber
C
C
Yeo
C
C
D000230:Adenocarcinoma / Q000235:genetics / Q000628:therapy*; D019496:Cancer Vaccines / Q000627:therapeutic use*; D002985:Clinical Protocols; D015316:Genetic Therapy / Q000379:methods*; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000235:genetics; D006801:Humans; D010190:Pancreatic Neoplasms / Q000235:genetics / Q000628:therapy*; D018579:Patient Selection; D014611:Vaccination
D019496:Cancer Vaccines; D016178:Granulocyte-Macrophage Colony-Stimulating Factor